Apolipoprotein B
Biomarker11 papers2 findings
- Humans2
Interventions
1Lerodalcibep
downin humans1
1 study
Lerodalcibep
downin humans1
Lerodalcibep decreases Apolipoprotein B in humans.
Reviewin patients with hypercholesterolemia
Lerodalcibep-liga as an Injectable Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9)-Targeted Therapy for Patients With Hypercholesterolemia · The Annals of pharmacotherapy · 25 Sep 2026
Associations
1Cardiovascular disease
upin humans1
1 study
Cardiovascular disease
upin humans1
Apolipoprotein B raises the risk of cardiovascular disease in humans.
“linking metabolic dysfunction, chronic low-grade inflammation, and cumulative exposure to apolipoprotein B (ApoB)-containing lipoproteins with atherosclerotic cardiovascular disease”
Reviewcumulative exposure
Bridging the evidence-to-practice gap in cardiometabolic prevention: from episodic care to lifelong, system-wide responsibility · Frontiers in public health · 14 Sep 2026
Latest
12Frontiers in Cardiovascular MedicineReview
Apolipoprotein E ε3/ε4 and coronary artery disease: lipid and non-lipid mechanisms in personalized prevention - narrative review
Current Atherosclerosis ReportsReview
Non-HDL Cholesterol as a Predictor of Coronary Atherosclerosis in South Asians: A Narrative Review
Journal of Clinical LipidologyHumans
LDL-C equation disagreement as a threshold-integrity flag for orthogonal lipid confirmation
Current Problems in CardiologyReview
Personalized Primary Cardiovascular Prevention: The Convergences of Risk Scores, Coronary Calcium Scoring and Lipoprotein (a)
Frontiers in Public HealthReview
Bridging the evidence-to-practice gap in cardiometabolic prevention: from episodic care to lifelong, system-wide responsibility
JACC Basic to Translational ScienceCells
Rates of Lipoprotein(a) Oxidation Accelerate at Elevated Levels and Attenuate With Atorvastatin Active Metabolites Compared With Other Statins
Journal of Diabetes and Metabolic DisordersHumans
Discordantly high apolipoprotein B despite normal LDL cholesterol across AHA PREVENT cardiometabolic risk strata among U.S. adults
International Journal of Molecular SciencesReview